A Phase I Trial of HS-10241 in Solid Tumors
NCT02759640
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasm
Solid Tumors
Interventions
DRUG:
HS-10241
Sponsor
Atridia Pty Ltd.